| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 103.85M | 106.95M | 141.59M | 212.78M | 324.52M |
| Gross Profit | 91.16M | 97.71M | 126.31M | 71.87M | 101.87M |
| EBITDA | 54.18M | -53.19M | -57.05M | 7.08M | -173.90M |
| Net Income | 71.45M | 41.23M | -159.97M | -52.55M | -250.06M |
Balance Sheet | |||||
| Total Assets | 1.71B | 1.74B | 2.21B | 2.64B | 3.37B |
| Cash, Cash Equivalents and Short-Term Investments | 279.45M | 273.02M | 481.51M | 411.60M | 571.67M |
| Total Debt | 618.92M | 679.24M | 1.14B | 1.38B | 1.80B |
| Total Liabilities | 878.47M | 1.00B | 1.51B | 1.77B | 2.36B |
| Stockholders Equity | 748.82M | 657.24M | 620.71M | 789.73M | 923.82M |
Cash Flow | |||||
| Free Cash Flow | -2.62M | 72.17M | 285.44M | 246.19M | 589.24M |
| Operating Cash Flow | -1.28M | 73.37M | 286.82M | 247.17M | 590.73M |
| Investing Cash Flow | 32.16M | 64.62M | -18.97M | 21.02M | 6.59M |
| Financing Cash Flow | -35.90M | -312.18M | -221.00M | -406.41M | -633.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | HK$548.00M | 10.49 | 5.52% | 5.43% | -8.15% | 14.16% | |
78 Outperform | HK$700.40M | 7.81 | 6.16% | 5.46% | 32.46% | 9.09% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
53 Neutral | HK$157.81M | 2.23 | 10.28% | ― | -4.57% | 72.53% | |
47 Neutral | HK$452.08M | -0.70 | -12.87% | 9.77% | 9.41% | -219.96% | |
44 Neutral | HK$741.64M | -3.87 | -8.70% | ― | 0.02% | -107.29% |